New research suggests supplemental cinnamon could improve fasting blood glucose and glucose tolerance among patients with prediabetes. Results of the 12-week study, which was conducted by an international team of investigators, indicate cinnamon could be a cost-effective approach to reducing progression from prediabetes to type 2 diabetes. Read more
High body mass index (BMI) in early life has been thought to increase the risk of developing chronic conditions like diabetes as an adult. It is challenging to study, as many people who have larger body sizes are also larger in adulthood; it is unclear whether adulthood lifestyle changes can lessen the risks from childhood […]
Researchers examining the importance of daytime-dependent fluctuations in intestinal bacteria have found that “arrhythmic” gut bacteria—bacteria that do not change between day and night—may be markers of potential type 2 diabetes. Read more
Many previous studies have suggested that there are shared risk factors between type 2 diabetes and cancer. Type 2 has been associated with a lower risk of prostate cancer, but a higher risk of kidney, colorectal, liver, breast, and pancreatic cancer, as well as a higher risk for overall cancer. Read more
A large study of people with type 2 diabetes who had gastric bypass surgery found that their risks for all-cause mortality, cardiovascular disease, acute myocardial infarction, and congestive heart failure were all lower after the surgery. They also had reduced risk of kidney disease, hyperglycemia, cancer, and leg amputations. However, there were also some negative […]
Researchers at the University of Manchester, U.K., found that more 77% of the people with type 2 diabetes studied had at least one other physical or mental health condition, at higher rates than in people without diabetes. These conditions included many that have not been previously thought to be linked to diabetes, such as schizophrenia, […]
Obstructive sleep apnea (OSA) is a common condition that causes a partial or complete block of your upper airway while sleeping. People with OSA are at higher risk of metabolic disorders like type 2 diabetes. Obesity is a common risk factor for both OSA and type 2 diabetes. Read more
A new study examined randomized trials of glucose-lowering drugs, including SGLT2 inhibitors and GLP-1 agonists, and assessed drug effectiveness for four categories of patients: diabetes drug-naive or those taking metformin at low or high risk of cardiovascular disease (CVD). Read more
Drugs originally developed to treat Alzheimer’s Disease could be re-purposed to prevent, or possibly even reverse, the damage done to the blood vessels in people who have obesity or type 2 diabetes, researchers say. Both type 2 and obesity can contribute to stiffening of blood vessels, which increases risk for heart attack or stroke. Read […]
Previous studies have shown that people with diabetes have worse outcomes after stroke. The Stroke and Cognition (STOKOG) Collaboration study looked closely at prediabetes (impaired fasting glucose) and type 2 diabetes to determine which condition causes worse cognitive function in patients 3 to 6 months after stroke. Read more
A large study of Taiwanese people with type 2 diabetes examined the relationship between the intake of macronutrients, such as carbohydrates, proteins, and fats, and mortality. The researchers found dietary patterns affect men and women differently. Read on
The Centers for Disease Control (C.D.C.) estimates that 2% to 10% of pregnant women will develop gestational diabetes (G.D.M.), and of women with G.D.M, up to 50% will go on to develop type 2 diabetes (T2D). Current testing to predict which women are at greater risk for T2D is cumbersome, but a new test may […]
Currently there is no such thing available as a once-weekly insulin product. However, a new type of insulin, called insulin icodec, is showing promise in testing, and may one day offer people with type 2 a more convenient option for taking insulin. Read more
A new study shows that metformin, a common type 2 diabetes drug, may have a previously unknown mechanism of action, involving the release of sugars in the blood from the intestines into the stool. Better understanding of how metformin works could eventually lead to development of new and improved diabetes medications. Read more
In treating type 2 diabetes, the first-line option is typically metformin. When metformin alone isn’t achieving the patient’s goals, the second and third-line options for pharmacological treatment are complex, with multiple drug classes and multiple drugs within those classes. A new analysis looks at the pros and cons of some key combinations. Read more
A large study of Israeli teen body mass index (BMI) found body mass in adolescence affects risk of developing type 2 as an adult, with young women with obesity most at risk for the disease. Read more
Signs a child may grow up to be susceptible to type 2 diabetes as an adult can be seen in children as young as 8 years of age, researchers say. They looked at the effects of a genetic risk score for developing type 2 diabetes in a large study of children in the UK, and […]
Imeglimin is a new, first-in-class blood-glucose-lowering drug. It is currently in phase 3 trials and has so far proven to be safe and efficient whether used alone or in combination with other drugs to lower A1C in patients with type 2 diabetes. Read more
Research on breastfeeding and type 2 diabetes suggests breastfeeding for longer may reduce the risk of future type 2 in women with a history of gestational diabetes. Having gestational diabetes puts women at a 7-fold higher risk of later developing type 2, compared to women who did not have gestational diabetes during their pregnancies. Read more
Arterial stiffness is a complication of cardiovascular diseases (CVD), which often affect people with type 2 diabetes. Past research has found lifestyle and behaviors including diet and exercise can have an effect on the development of arterial stiffness. A recent study looked at whether skipping breakfast, specifically, could be a factor. Read more
